AMC [AMC ENTERTAINMENT] 8-K/A: (Original Filing)
[]
UTSI [UTSTARCOM] SC 13D/A: (Original Filing)
[GU GUOPING 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) ý 3. SEC Use Only 4. Source of Funds (See Instructions) AF]
BSPM [Biostar Pharmaceuticals] 8-K: (Original Filing)
[Biostar Regains Compliance with NASDAQ Continued Listing Requirement XIANYANG, China, December 4, 2017 /PRNewswire/ - Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) (“Biostar” or “the Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced t]
SGOC [SGOCO] SC 13D: (Original Filing)
[2. See Check the Appropriate Box if a Member of a Group ( (a) ¨ (b) ¨ 3. SEC Use Only: 4. PF Source of Funds (See Instructions): 5. ¨ 6. Hong Kong Citizenship or Place of Organization:]
CCCR [China Commercial Credit] PRER14A: (Original Filing)
[CHINA COMMERCIAL CREDIT, INC. No.1 Zhongying Commercial Plaza, Zhong Ying Road, Wujiang, Suzhou, Jiangsu Province, China TO THE STOCKHOLDERS OF CHINA COMMERCIAL CREDIT, INC.: CCCR Company we us our You are cordially invited to attend a special meeting of the stockholders of China Commercial Credit, ]
XIN [Xinyuan Real Estate] 6-K: (Original Filing)
[XINYUAN REAL ESTATE CO., LTD. UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE COMMON DEPOSITARY (AS DEFINED IN THE INDENTURE GOVERNING THIS NOTE) TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME O]
CISG [FANHUA] 6-K: (Original Filing)
[Fanhua Updates the Record Date of its Upcoming Quarterly Dividend Payment US$0.01 per ordinary share, or US$0.20 per ADS, which will be The dividend remains payable on or around December 22, 2017. GUANGZHOU, China, December 1, 2017 (GLOBENEWSWIRE) – Fanhua Inc. (Nasdaq: FANH) (the “Company” or “Fanh]
CYD [CHINA YUCHAI INTERNATIONAL] 6-K: (Original Filing)
[COMPLETION OF THE SALE BY HL GLOBAL ENTERPRISES LIMITED OF ALL ITS SHARES IN LKN INVESTMENT INTERNATIONAL PTE. LTD. Singapore, Singapore December 1, 2017 On a preliminary basis, the Company expects to record a profit after tax of RMB320.0 million and a profit attributable to equity holders of th]
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac Biotech Cures Nasdaq Filing Deficiency BEIJING, December 1, 2017 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA)(the “Company” or “Sinovac”), a leading provider of biopharmaceutical products in China, announced today that it has received a Nasdaq Staff letter indicating that the Form 20-F]
